In one paragraphArticle in Infection and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Pauline IkpaDivision of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-3523-6318 Amanda NengelDivision of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
James B KaperDepartment of Microbiology & Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-0715-2907 Mark DonowitzDivision of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-0477-8824 Jennifer Foulke-AbelDivision of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-3882-5625 Funding
Project 3 - Human colonoids as a model for the pathobiology of EHECP01AI125181 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KAPER, JAMES B · 2016 to 2025
$18.6MTranslational Research Enhancement CoreP30DK089502 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI KOVBASNJUK, OLGA · 2011 to 2020
$12.0MA Human Enteroid Model of Cholera Toxin PathophysiologyK01DK113043 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI FOULKE-ABEL, JENNIFER · 2018 to 2022
$791kOlympus FluoView3000RS Confocal MicroscopeS10OD025244 · OD · JOHNS HOPKINS UNIVERSITY · PI O'ROURKE, BRIAN · 2018 to 2018
$448kNIAID NIH HHS P01 AI125181NIDDK NIH HHS K01 DK113043NIDDK NIH HHS P30 DK089502NIH HHS K01DK113043NIH HHS P01AI125181NIH HHS P30DK089502NIH HHS S10 OD025244NIH HHS S10OD025244
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Enterotoxigenic Escherichia coliEscherichia coli InfectionsFlagellaHost-Pathogen InteractionsImmunity, InnateEpithelial CellsEscherichia coli ProteinsFlagellinGene Expression ProfilingGene Expression Regulation, BacterialHumansMacrophagesToll-Like Receptor 5Escherichia coli ProteinsFlagellinToll-Like Receptor 5CXCL6IL-17Cintestinal organoid monolayersprimary monocyte-derived macrophagesvaccine strain engineering
Identifiers
PMID42752214
PMCPMC13647256
What OpenQuestion holds
Textmetadata
Read underepoch 390